Answers are grounded in this paper and cite their sources.
We evaluated the awareness of HPV, HPV vaccine and HPV-associated cancers among Arab Americans. This was a cross-sectional study conducted between March and July 2023 among self-identifying Arab Americans residing in Southeast Michigan (n = 295). Adjusted multivariable logistic regression models estimated the associations between HPV, the vaccine and HPV-associated cancers (cervical, anal, oropharyngeal, penile, vaginal, and vulvar) awareness and sociodemographic and behavioral factors. Awareness of HPV-associated cancers were as follows: cervical (50.5%), vaginal (48.4%), vulvar (42.4%), penile (41.5%), anal (41.5%), and oropharyngeal (37.9%) cancers. In the multivariable logistic regression models, compared to females, males had lower odds of being aware that HPV can cause cervical (aOR = 0.38; 95% CI: 0.20–0.73), anal (aOR = 0.50; 95% CI: 0.26–0.95), vaginal (aOR = 0.40; 95% CI: 0.21–0.76), and vulvar (aOR = 0.51; 95% CI: 0.27–0.97) cancers. Similarly, respondents with some college/associate degree had lower odds of being aware that HPV can cause cervical (aOR = 0.31; 95% CI: 0.14–0.69), anal (aOR = 0.31; 95% CI: 0.14–0.70), oropharyngeal (aOR = 0.34; 95% CI: 0.15–0.80), penile (aOR = 0.32; 95% CI: 0.14–0.71), vaginal (aOR = 0.30; 95% CI: 0.14–0.66), and vulvar (aOR = 0.34; 95% CI: 0.15–0.75) cancers compared to those with college degrees. This underscores the necessity for targeted interventions to improve awareness among this population.
No takes yet. Share an insight, caveat, or question.
Al‐Antary et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: